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Introduction
Globally, more than 14 million new cases of cancer will occur each 
year and the number of people with this disease expected to triple by 
2030, because of survival (DGS) [1-3]. Survivors continue to experience 
significant limitations, compared to those without a history of cancer 
[4]. The presence of symptoms persists permanently, resulting from the 
direct adverse effects of cancer, treatment, exacerbation and/ or onset of 
new ones, associated with recurrence or second tumor [5,6].
Pain, dyspnea, fatigue, emotional distress arises simultaneously 
and is interdependent. In this way, the term cluster symptoms become 
known when two or more symptoms are interrelated, since they 
can share the same etiology and produce a cumulative effect on the 
person’s functioning. Richards et al. [7] found that patients with a 
high prevalence of pain were more likely to be treated with high-
dose pain relief than those who did not. The incidence of pain at the 
onset of the disease pathway is estimated at 50% and is increased to 
approximately 75% at advanced stages, which means that the survivor 
does not experience it only as an immediate treatment outcome [8-
11]. In an advanced stage of the oncological disease, dyspnea is one 
of the symptoms that assumes relevance, often arises associated with 
pain (about 45%), represented a cluster symptoms inducer of greater 
anxiety and fatigue. That is responsible for the demand for health care, 
so it is fundamental a serious investment in their control [12]. The 
objective of this systematic review of the literature is to identify non-
pharmacological strategies in the control of pain and dyspnea, of the 
patients with oncological disease, in acute care.
Discussion
The assessment of pain is considered the first step towards effective 
pain control, which includes self-assessment tools that enable a more 
measurable dimension, where the person’s speech is the gold standard 
in data collection. The characteristics of pain are influenced by the 
psycho-emotional state, the activities of daily living, the existence of 
other comorbidities and/or additive behaviors. The performance of 
previous or current oncological treatments, analytical and imaging data 
was related to the etiology of pain. This aspect is considered fundamental 
in a comprehensive analysis of the person with cancer pain [13-15]. The 
non-pharmacological strategies are the person-centered care, which 
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Summary
To identify non-pharmacological strategies in the control of pain and dyspnea, in patient with oncological 
disease, in acute care. The gold standard to an adequate symptom control is a systematized assessment. 
Non-pharmacological measures: psycho-emotional support, hypnosis, counseling/ training/ instruction, therapeutic 
adherence, music therapy, massage, relaxation techniques, telephone support, functional and respiratory 
re-education increase health gains. The control of oncologic pain and dyspnea require a comprehensive and 
multimodal approach.
emphasizes the individualization and inclusion of a significant person 
that increases health outcomes. Directed interventions for counseling, 
education for self-management, training / instruction, telephone follow-
up, health literacy and nurses as case manager, with interconnection 
with other health professionals and health services increase therapeutic 
adherence and satisfaction with care [16,17]. Therapeutic massage, 
hot and/ or cold application, positioning, hypnosis, transcutaneous 
electrical nerve stimulation and music therapy are considered measures 
that improve the effectivity of medication regimen [18,19].
In the evaluation of dyspnea, the literature suggests the use of the 
acronym O, P, Q, R, S, T, U and V to better evaluate its characteristics: 
(onset) frequency, provoking factors of relief and exacerbation, 
(Quality) description of the dyspnea sensation, (region/radiaton) the 
existence of other symptoms simultaneously, (severity) intensity of 
dyspnea, (Treatment) medication used for its control, efficacy and 
adverse effects, (Understanding) dyspnea on human living, (Values) 
the level of acceptable / desirable dyspnea intensity for the person. The 
instruments to be included in its assessment are: the Edmonton System 
Assessment Scale, Clinical Anxiety and Depression Scale - HADS, 
Modified Dyspnea Index (MDI) and Numerical Rating Scale (NRS) for 
breathlessness, Modified Borg and Chronic Respiratory Questionnaire. 
The etiology of dyspnea should be carefully investigated to determine 
the need of other complementary techniques for its relief [20-22].
Non-pharmacological strategies aimed at functional and respiratory 
rehabilitation, cold application, adoption of healthy lifestyles, education 
for self-management/counseling, psycho-emotional support and 
relaxation/ visualization exercises in anxiety control and referral to 
others health professionals/ services allow better control of dyspnea 
(ONS, 2011) [23-27].
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Conclusion
The efficacy of the drug regimen and/ or adverse effects control 
can be enhanced by the use of non-pharmacological techniques 
simultaneously, which contribute to the reduction of basal pain 
intensity and control of exacerbations, increase comfort, well-being, 
reduce the level of anxiety, pain and dyspnea, which are results sensitive 
to nursing care [28]. The combination of two or more symptoms 
experienced at the same time, can lead to high levels of distress, which 
when undervalued or subtreated predispose to the appearance of 
burden symptoms. Concomitantly, the manifestation of a symptom 
rarely occurs in isolation, so both assessment and treatment requires a 
comprehensive and multi-modal approach.
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